FDA grants accelerated approval for first engineered T cell therapy to treat adults with synovial sarcoma

Roche’s Genen­tech unit will cut 3% of work­ers, a spokesper­son told End­points News Wednes­day, mak­ing it the lat­est drug­mak­er to an­nounce staffing re­duc­tions in re­cent

BeiGene is build­ing a fourth fa­cil­i­ty in Chi­na with a bud­get of $74 mil­lion for the land and con­struc­tion. Ac­cord­ing to its first-quar­ter earn­ings in

WASH­ING­TON — FDA Com­mis­sion­er Robert Califf ap­peared be­fore the House Over­sight Com­mit­tee on Thurs­day to plead his case again for more au­thor­i­ty to mon­i­tor the